Table 2 Changes in Serum Creatinine and eGFR According to Coexisting Conditions
From: Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography
Group | DM with nephropathy | DM without nephropathy | CKD | HF |
|---|---|---|---|---|
Number | 15 | 61 | 27 | 7 |
Age | ||||
median | 55 | 59 | 53 | 63 |
interquartile range | 46–66 | 50–69 | 42–64 | 46–68 |
Sex (M/F) | 7/8 | 35/26 | 22/5 | 3/4 |
Pre-SCr (mg/dL) | ||||
median | 1.60 | 1.16 | 2.84 | 1.33 |
interquartile range | 1.21–3.20 | 0.89–1.67 | 1.50–4.99 | 0.77–1.49 |
Post-SCr (mg/dL) | ||||
median | 1.70 | 1.20 | 2.74 | 1.31 |
interquartile range | 1.27–3.20 | 0.89–1.74 | 1.42–4.58 | 0.84–1.67 |
p value | 1.000 | 0.131 | 0.115 | 0.735 |
Pre-eGFR (mL/min/1.73 m2) | ||||
median | 38.68 | 55.76 | 24.00 | 54.94 |
interquartile range | 17.28–49.36 | 35.84–72.76 | 13.00–39.00 | 38.68–79.36 |
Post-eGFR (mL/min/1.73 m2) | ||||
median | 36.32 | 55.88 | 26.00 | 58.83 |
interquartile range | 20.00–47.00 | 31.91–72.68 | 15.21–47.00 | 33.91–71.78 |
p value | 0.398 | 0.170 | 0.679 | 0.310 |